High Content Imaging and its benefits in the preclinical stages

30th April 2021
11:00 am - 11:30 am CEST
Presented by: Dr. Noelle J.A. Ali, OLS OMNI Life Science. The early and preclinical stages of the drug discovery process involve high-throughput screenings for target identification and validation. Rapid and automated imaging systems are very advantageous for high content imaging. This webinar will provide information on rapid batch imaging and analysis for identifying and validating potential drug/therapeutics candidates in a high-throughput manner.

    * You can change your preference or unsubscribe at any time with the links included in any of our emails, or by contacting us at info@ols-bio.de. We will treat your information with respect and in accordance with the legal data protection regulations and our privacy policy.

    Subscribe for our newsletter

    e-mail required
    By submitting my data and sending the registration, I agree to receive the newsletter ordered here by email. My data will not be disclosed to third parties. I can revoke this consent at any time. More detailed information in the Privacy Policy section
    OLS OMNI Life Science Your Partner in Cell Research
    Imprint | Privacy Policy | Terms and Conditions